Evidence map›Paper›PMID 27341653›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2016

Identification of Senescent Cells in the Bone Microenvironment.

Joshua N Farr, Daniel G Fraser, Haitao Wang, Katharina Jaehn, Mikolaj B Ogrodnik, Megan M Weivoda, Matthew T Drake, Tamara Tchkonia, Nathan K LeBrasseur, James L Kirkland and 4 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05637216 (A Pilot Study of Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients), which is not on this map. Cited by 349 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
349citing papers in PubMed, 2 pooled it
16.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05637216 phase2active not recruitingnot on this mapstarted 2023, after this paper: background citation

A Pilot Study of Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients

TypeinterventionalSponsorShaw Cancer CenterRan2023 to 2027Enrolled43ConditionsRadiation Induced FibrosisArmsLosartan 25 milligram capsule, Placebo
3 · Its place in the literature

Who cites it

349 citing papers in PubMed, 2 syntheses or guidelines pooled it, 529 citations in OpenAlex.

  1. Pooled it
  2. Consequences of Aging on Bone.Aging and disease · 2023
    Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Observational
  18. Review
  19. Article
  20. Review

289 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Joshua N FarrRobert and Arlene Kogod Center on Aging and Endocrine Research Unit, Mayo Clinic College of Medicine, Rochester, MN, USA.
Daniel G FraserRobert and Arlene Kogod Center on Aging and Endocrine Research Unit, Mayo Clinic College of Medicine, Rochester, MN, USA.
Haitao WangDepartments of Orthopaedic Surgery and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Katharina JaehnDepartment of Oral Biology, University of Missouri-Kansas City, School of Dentistry, Kansas City, MO, USA.
Mikolaj B OgrodnikRobert and Arlene Kogod Center on Aging and Endocrine Research Unit, Mayo Clinic College of Medicine, Rochester, MN, USA.
Megan M WeivodaRobert and Arlene Kogod Center on Aging and Endocrine Research Unit, Mayo Clinic College of Medicine, Rochester, MN, USA.
Matthew T DrakeRobert and Arlene Kogod Center on Aging and Endocrine Research Unit, Mayo Clinic College of Medicine, Rochester, MN, USA.
Tamara TchkoniaRobert and Arlene Kogod Center on Aging and Endocrine Research Unit, Mayo Clinic College of Medicine, Rochester, MN, USA.
Nathan K LeBrasseurRobert and Arlene Kogod Center on Aging and Endocrine Research Unit, Mayo Clinic College of Medicine, Rochester, MN, USA.
James L KirklandRobert and Arlene Kogod Center on Aging and Endocrine Research Unit, Mayo Clinic College of Medicine, Rochester, MN, USA.
Lynda F BonewaldDepartment of Oral Biology, University of Missouri-Kansas City, School of Dentistry, Kansas City, MO, USA.
Robert J PignoloDepartments of Orthopaedic Surgery and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
David G MonroeRobert and Arlene Kogod Center on Aging and Endocrine Research Unit, Mayo Clinic College of Medicine, Rochester, MN, USA.
Sundeep KhoslaRobert and Arlene Kogod Center on Aging and Endocrine Research Unit, Mayo Clinic College of Medicine, Rochester, MN, USA.
Mayo Clinic in Florida · USRobert Koch Institute · DEOrthopaedic Research · GBUniversity of Missouri–Kansas City · US

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
SEX STEROIDS, GROWTH FACTORS, &BONE CELL FUNCTIONP01AG004875 · NIA · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 1985 to 2019
$30.8M
Transgenic and Mechanical Loading CoreP01AG039355 · NIA · UNIVERSITY OF MISSOURI KANSAS CITY · PI BONEWALD, LYNDA F · 2012 to 2024
$19.3M
Mayo Clinic Center for Translational Science ActivitiesTL1TR000137 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$2.1M
The Role of Ror-Beta in the SkeletonR01AR068275 · NIAMS · MAYO CLINIC ROCHESTER · PI MONROE, DAVID G · 2015 to 2019
$1.7M
Osteoporosis and osteoblast differentiation in mouse models of accelerated agingR01AG028873 · NIA · UNIVERSITY OF PENNSYLVANIA · PI PIGNOLO, ROBERT JOHN · 2007 to 2011
$1.6M
Estrogen receptor regulation of bone metabolism in adult miceR01AG048792 · NIA · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP, MONROE, DAVID G · 2015 to 2019
$1.0M
NCATS NIH HHS TL1 TR000137NCATS NIH HHS UL1 TR000135NIAMS NIH HHS R01 AR068275NIA NIH HHS P01 AG004875NIA NIH HHS P01 AG039355NIA NIH HHS R01 AG028873NIA NIH HHS R01 AG048792
6 · The paper itself

Abstract

Cellular senescence is a fundamental mechanism by which cells remain metabolically active yet cease dividing and undergo distinct phenotypic alterations, including upregulation of p16

Indexed as

Cellular MicroenvironmentCellular SenescenceAnimalsBiomarkersBone and BonesCell LineageCells, CulturedCyclin-Dependent Kinase Inhibitor p16DNA, SatelliteFemaleMaleMice, Inbred C57BLMyeloid CellsOsteoblastsOsteocytesPhenotypeBiomarkersCyclin-Dependent Kinase Inhibitor p16DNA, SatelliteAGINGANIMAL MODELSCELL/TISSUE SIGNALINGOSTEOCYTES

Identifiers

PMID27341653
PMCPMC5289710
OpenAlexW2467271588

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.